Innogenetics and Bio-Rad enter into a non-exclusive licensing agreement for HIV-2 patents

26-Feb-2007

Innogenetics and Bio-Rad Laboratories, Inc. announced that the two companies have finalized a non-exclusive licensing agreement for patents in the field of viral diagnostics. According to the terms of the non-exclusive agreement, Innogenetics will get a license from Bio-Rad that has exclusive rights in the field of HIV-2. Bio-Rad will get an option to a non-exclusive license under Innogenetics patents in the field of HCV genotyping.

Under the agreement, Innogenetics will be granted a non-exclusive license to Bio-Rad's intellectual property in the field of HIV-2 immunoassays and, consequently, all legal proceedings between Innogenetics, Institut Pasteur, Bio-Rad Pasteur, and Bio-Rad Laboratories b.v. will be terminated. The HIV-2 license granted to Innogenetics covers all territories (except the USA and Canada) and runs until the expiration of the last to expire of the licensed patents.

The proceedings were initiated by the aforementioned parties in 1998 and were related to the Institute Pasteur's European patents EP 239 425 and EP 283 327. Based on these patents, claims were pending against Innogenetics at the Courts of Antwerp and Gent, respectively.

In addition, Bio-Rad will be granted an option to Innogenetics HCV genotyping patents. This option is non-exclusive and covers all territories.

Other news from the department business & finance

Most read news

More news from our other portals

So close that even
molecules turn red...

See the theme worlds for related content

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

1 products
1 whitepaper
1 brochures
View topic world
Topic world Diagnostics

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

1 products
1 whitepaper
1 brochures